News Releases

The Texas Heart Institute (THI), a globally renowned cardiovascular health center, and BiVACOR , a leading clinical-stage medical device company, are pleased to provide an update on the condition of the first patient to receive the BiVACOR Total Artificial Heart (TAH) implant on July 9, as part of the U.S. Food and Drug Administration (FDA) Early Feasibility Study (EFS).

First-in-human novel valveless artificial heart implanted in a patient with end-stage heart failure as a bridge to heart transplant.

Biomedical engineer Daniel Timms lost his father to heart disease. By then, thanks in part to the pair’s kitchen-bench experiments, the unassuming Queenslander was well on his way to inventing a permanent, total artificial heart.

Biomedical engineer Daniel Timms lost his father to heart disease. By then, thanks in part to the pair’s kitchen-bench experiments, the unassuming Queenslander was well on his way to inventing a permanent, total artificial heart.

Using magnetic levitation technology, the world’s first long-term artificial heart won’t wear out, age or break. It’s small enough for a child’s chest yet robust enough to pump life into an active adult, and it’s about to be implanted in human bodies for the very first time.

Grant From Monash University’s Artificial Heart Frontiers Program, supported by the Australian Government’s Medical Research Future Fund, to advance medical technologies for severe heart failure.

BiVACOR Total Artificial Heart (TAH) is being touted as the “revolutionary, Australian-made, implantable mechanical device.

BiVACOR, Inc., a clinical-stage medical technology company developing a total artificial heart (TAH), today announced that Jim Dillon has been named chief executive officer and a member of its board of directors.

BiVACOR, Inc., a clinical-stage medical technology company developing a total artificial heart (TAH), today announced that Raymond W. Cohen has been appointed chairman of its board of directors.

The study is anticipated to commence in 2024 and will pave the way for a subsequent pivotal study.

Funds will support studies of its Total Artificial Heart for the first in human early feasibility studies.

BiVACOR moves in to GCHKP to collaborate with Griffith University.

Houston-based BiVACOR, a preclinical medical device company, raised $22 million through a Series B capital raise and a grant award.

Millions of hearts fail each year. Why can’t we replace them?

NASA’s Johnson Space Center is pairing with BiVACOR, Inc., to improve the robustness and reliability of the company’s Total Artificial Heart system.

Inside Bivacor’s artificial heart, a levitating disk spins 2000 times per minute to keep blood flowing.

Daniel Timms spent his childhood learning the mechanics of plumbing from his father. Today he is using that knowledge to create a ground-breaking artificial heart device with the potential to prolong the lives of millions of people with heart failure.

For patients with congestive heart failure, mechanical replacements can’t come soon enough.

A miracle small enough to be implanted inside a child so that they can walk, run, eat, drink, dance and live fully independently without a human heart and without a pulse.

Scientists at the Texas Heart Institute are working to create a permanent artificial heart. The new heart device propels blood through the body, rather than pumps it. Two magnetic fields control the blades’ oscillations, which rotate about 2,000 times a minute.

Dr Daniel Timms’ work was honoured with the QUT Young Alumnus of the Year award at the annual Outstanding Alumni Awards at the Brisbance Convention and Exhibition Centre this week.

Australian engineer’s device has lots of believers here.

The world’s elite heart surgeons have long and fruitlessly sought to develop a replacement for the muscle continually thumping inside our chests.

Could it really be, then, that a 39-year-old mechanical engineer from Australia’s Gold Coast will succeed where the luminous DeBakeys, Cooleys, Jarviks and Fraziers failed?

Some sharp people in Houston already think so. In fact, they’re betting $2.1 million that Aussie Daniel Timms is the bloke for the job.

Among the believers are Dr. Denton Cooley, who founded the Texas Heart Institute 50 years ago, and Dr. Bud Frazier, a surgeon there who has transplanted more hearts than anyone in the world, and a principal in the development of multiple heart pumps and artificial hearts.

An artificial heart and a modular bathroom for the mining industry are among the 31 innovations to win up to $50,000 funding as part of a program titled What’s your big idea Queensland?